N-methyl-D-aspartate receptors (NMDAR) have a recognized role in neuronal plasticity while their excessive activation results in excitotoxic death.
may also enhance or even directly trigger neuronal death. The pro-or anti-survival outcome of these signals may depend on the type of receptors, stimulation intensity and/or the signaling context. Indeed, important survival signals in CNS neurons including neurotrophins or glutamate can also trigger neuronal death [6, 7] . This review focuses on the signaling mechanisms that are activated by NMDAR to support neuronal survival. As the signaling pathways that are discussed in this paper were extensively reviewed before [14] [15] [16] [17] [18] [19] [20] [21] [22] , we decided to concentrate on their demonstrated connections to the NMDARmediated protection. Because the field of NMDAR-regulated survival signaling is just emerging, we chosen to abstain from proposing connections between various identified mediators of protective NMDAR activity unless that was directly demonstrated in a single study using the same NMDAR-stimulated system. Instead, we present the evidence implicating various signaling mediators/effectors that we grouped into 6 functional categories including (i) NMDAR subtypes, (ii) prosurvival signaling kinases, (iii) pro-apoptotic signaling kinases, (iv) transcription factors, (v) trophic factors and (vi) components of cell death machinery that directly regulate mitochondrial death signals and/or caspase activity. A hypothetical model of the NMDAR-activated survival signaling network is presented in the Figure 1 . Importantly, the elements of the network depicted in that model and/or discussed in this review may be cell type-/cell injuryspecific. The information on the cell types and cell death models in which a given NMDAR-activated survival signaling mediator was implicated is provided in the text and in the Tables 1 and 2. Glutamate is the main excitatory neurotransmitter in the CNS. It activates multiple types of receptors including the Nmethyl-D-aspartate receptors (NMDAR). NMDAR form calcium-permeable ion channels and are principal mediators of the excitotoxic cell death following excessive release of glutamate after various forms of CNS insults [7] . Unfortunately, in clinical trials, NMDAR antagonists showed only limited neuroprotective potential [8, 9] . This likely was a consequence of undiscriminative NMDAR inhibition that blocked excitotoxicity as well as physiological processes that are under NMDAR control including CNS plasticity and neuronal survival [10] [11] [12] [13] . Therefore, successful neuroprotection by NMDAR blockade may require a new generation of antagonists which will selectively block glutamate exicotoxicity while either unaffecting or increasing the pro-survival activity of NMDAR. Design of such drugs could be facilitated by identification of the signaling switches that determine the outcome of NMDAR stimulation. Noteworthy, the different use of various NMDAR subtypes as well as their differential coupling to diverse intracellular signaling pathways could provide opportunities for selective antiexcitotoxic/pro-survival interventions. Hence, studies aimed on identification of the mediators of NMDAR-activated survival signaling are important not only for the understanding of the basic mechanisms that control CNS development and/or CNS cell defense but also for the development towards clinically useful NMDAR antagonists.
Survival response mediated by NMDAR in the developing nervous system
The role of NMDAR in survival support was proposed based on the observations in cultured rat cerebellar granule neurons that survived better in the presence of depolarizing concentrations of KCl [23] . As this treatment was suggested to mimic the endogenous NMDAR-mediated glutamate signaling, it was hypothesized that NMDAR is required for survival of newly generated cerebellar granule neurons. Indeed, it was later shown that NMDAR activation by exogenous NMDA prevented the reduction of rat cerebellar granule neuron survival in suboptimal KCl concentrations [24, 25] . The NMDA protection was attributed to inhibition of cerebellar granule neuron apoptosis that followed KCl reduction [26] . Similarly, NMDAR antagonists triggered rat or mouse cortical neuron apoptosis in culture [27, 28] . In addition, these agents accelerated rat cortical neuron apoptosis that was induced by serum deprivation [29, 30] , while exogenous NMDA offered protection to serum-deprived rat cortical neurons [29] . Also, apoptosis in cultured rat retinal explants was attenuated by exogenous NMDA [31] . Finally, NMDAR antagonists reduced dopaminergic neuron survival in P2-P3 rat midbrain slice cultures [32] . Thus, pro-survival effects of NMDAR stimulation were found in several neuronal populations from the developing rodent CNS indicating the general role of glutamate as a source of trophic support.
This notion is also supported by observations in young animals that were treated with NMDAR antagonists. For instance, Gould and colleagues reported an increased number of pyknotic cells and degeneration in the hippocampal dentate gyrus of rat pups that were treated with NMDAR antagonists during the first week of life [12] . Also, a single administration of an NMDAR antagonist to P0, or P3, or P7 rat pups was shown to trigger neuronal apoptosis that was widespread throughout multiple forebrain structures including cortex, dentate gyrus, Ammon's horn, subiculum, caudate, thalamus and hypothalamus [13] . While transient blockade of NMDAR was insufficient to induce neuronal death in the developing rat cerebellum, chronic blockade resulted in extensive apoptosis in the cerebellar granular cell layer of P11 rat pups [33] . In addition, prenatal exposure of male rats to the NMDAR antagonist MK801 enhanced apoptosis in the sexually dimorphic nucleus of the preoptic area [34] . Finally, P0 mice pups lacking the NR1 NMDAR subunit that is required for NMDAR formation, demonstrated dramatic increase of developmental apoptosis in the thalamus [35] .
Interestingly, it was suggested that the apoptotic responses to decreased NMDAR activity correlate well with the period of synaptogenesis [35, 36] . Therefore, NMDAR may generate a signal that ensures survival of these neurons that successfully formed synapses. After synapses are established, the contribution of NMDAR to survival signaling would decrease as elder animals do not respond with neuronal apoptosis if NMDAR are blocked [13] .
It is unclear whether NMDAR play a role in survival signaling in primates. Ethanol, which in addition to other effects also antagonizes NMDAR, induced similar pattern of neuronal apoptosis as more specific NMDAR blockers if administered to rat pups [36, 37] . Prenatal ethanol exposure in humans can result in fetal alcohol syndrome which includes neuronal loss [37] . Therefore it was proposed that also in primates, NMDAR promote neuronal survival [36, 37] . Consequently, it was suggested that prenatal exposure to NMDAR antagonists including some anesthetics or substances of abuse might compromise neuronal survival during human brain development [36] .
It is important to distinguish the developmental toxicity of NMDAR blockade that results in apoptosis from the excitotoxic neuronal death in retrosplenial cortex of adult rodents treated with high doses of NMDAR antagonists [38] . The latter phenomenon is caused by a decrease in NMDAR-dependent neuronal inhibition and the resulting overexcitation rather than reduced pro-survival signaling via the NMDAR [39] . Thus, in the developing CNS, NMDAR activates an important antiapoptotic input that ensures survival of these neurons that established successful connections. In addition, it is possible that NMDAR provides a survival/proliferation signal for the neural stem cells/neuroblats during embryonic and, perhaps, adult neurogenesis [40] .
Survival response mediated by
NMDARs to protect from neuronal injuries.
In addition to their contribution to trophic support during development, NMDAR may also enhance survival of injured neurons. A good example of this activity is the role of NMDAR during ischemic pre-conditioning. In the gerbils the NMDAR antagonist MK801 blocked the protective effects of a brief ischemic episode against hipocampal neuron loss triggered by a longer ischemia period applied a few days later [41] . Also, in mouse cortical cultures, the protection by a brief period to oxygen/glucose deprivation against more intense oxygen/glucose deprivation one day later was sensitive to NMDAR antagonists [42] . Similarly, NMDAR antagonists increased neuronal apoptosis in cultured rat cerebellar granule neurons injured by arsenite [43] or in cortical neurons exposed to a DNA damaging drug, cisplatin [44] . Finally, NMDAR antagonists enhanced apoptosis induced by traumatic brain injury in rat pups [3] . The protective role of endogenous NMDAR activity in injured brain has been proposed to contribute to the failure of clinical trials which evaluated NMDAR antagonists as potential neuroprotective drugs in stroke or traumatic brain injury [9] .
In addition to basal NMDAR activity, also moderate stimulation of NMDAR was shown to protect against injuries. For instance, NMDA pretreatment protected cultured CGNs against cell death induced by glutamate or a neurotoxin, 1-methyl-4-phenylpyridinium ion (MPP+) [45] . Protective effects of NMDA pretreatment were reported in rat retinal explant cultures challenged with glutamate excitotoxicity or ionizing irradiation [46] . Likewise, NMDA reduced apoptosis in cortical neurons subjected to ethanol, or the PhoshpatidyloInositol-3-Kinase (PI3K) inhibitor, LY294002 [47, 48] . Finally, increased synaptic activity induced in cortical cultures by pharmacological agents was protective against various pro-apoptotic toxins including staurosporine, retinoic acid, ceramide or okadaic acid in an NMDARdependent manner [49, 50] . Hence, in CNS neurons, NMDAR activates survival signaling that may suppress both developmental apoptosis and injury-induced neuronal death. Noteworthy, the survival promoting activity of NMDAR was also found in several cancer cell lines and in keratinocytes [51] [52] [53] . This suggests that the trophic activity of NMDAR is not restricted to neurons.
Which subtypes of NMDAR mediate survival?
NMDAR are glutamate-gated ion channels composed of four subunits (for a review see [54] ). Each receptor includes two NR1 subunits and two NR2 subunits. While there is a single gene encoding NR1, four genes for NR2 subunits have been discovered. Hence, various combinations of NR2A, B, C or D proteins contribute to heterogeneity of NMDAR, which may be further enhanced by alternative splicing or differential inclusion of modulatory NR3 subunits into the receptor [54] . Various subtypes of NMDAR demonstrate different expression patterns in adult brain [54] . Also, their expression changes during brain development [54] . Finally, different NMDAR may be present in various areas of neuronal plasma membrane [54] . It is tempting to speculate that these differences may contribute to diversity of neuronal responses to NMDAR stimulation.
However, the presence of NR2B is not necessary for NMDAR-stimulated survival. Indeed, cultured cerebellar granule neurons are strongly protected by NMDA even though their predominant NMDAR are NR2A and NR2C, but not NR2B [56] . Therefore, it is likely that dependent on the subtype of NMDAR that is involved in promoting survival, there may be differential engagement of signaling pathways that underlie this activity. In addition, as demonstrated for BDNF signaling [60] , the protective circuitries may be used differently against various neuronal death stimuli that are antagonized by NMDAR. Hence, it is important to identify which intracellular signaling pathways are involved in NMDAR-dependent neuroprotection.
Consistent with this, a recent report demonstrated that different NMDAR subtypes mediate different forms of synaptic plasticity [55] .
In rat cortical or hippocampal neurons, the major NMDAR subtypes include NR2A or NR2B containing receptors [54, [56] [57] [58] . While the relative NR2B contribution to NMDAR is high at early stages of development, NR2A participation becomes predominant postnatally reaching its maximum in adults [58] . In the mature hippocampus, NR2B receptors were proposed to be predominatly at extrasynaptic locations while NR2A receptors would be at the synapses [57] . On the other hand, at early stages of development, NR2B receptors are major synaptic NMDAR [57, 59] .
Role of Ca 2+ /calmodulin dependent kinases in pro-survival NMDAR signaling
The influx of extracellular Ca 2+ that follows NMDAR activation is critical for NMDAR coupling to the intracellular signaling pathways. These include Ca 2+ /calmodulin dependent kinases (CaMKs) [22] . In cultured rat cerebellar granule cells, pharmacological intervention with a CaMKII and CaMKIV inhibitor KN62, blocked the protective effects of exogenous NMDA against exposure to low level K + media [61] . Also, a calmodulin inhibitor, W13 showed similar activity [62] . In NG108 neuroblastoma cells, a dominantnegative mutant form of CaMK kinase (CaMKK) inhibited NMDA protection against serum withdrawal-induced apoptosis [51] . The neuroprotective effects of the NMDAR-activated CaMKK were attributed to its ability to directly phosphorylate and activate the protein kinase Akt [51] . Also, in cerebellar granule neurons, Akt was shown to be downstream of calmodulin in an NMDAR-activated protective pathway [62] . In addition, KN62 blocked the NMDARdependent protection obtained in rats by ischemic preconditioning [63] . This was proposed to be due to the requirement of CaMK for Akt activation [63] . Thus, Availability of NMDAR antagonists specific for NR2B NMDAR has enabled investigators to address the issue of NMDAR identity in pro-survival glutamate signaling. For instance, in cultured rat cortical neurons, a NR2B-specific antagonist, ifenprodil blocked excitotoxicity [49] . This led to a proposal that presumably extrasynaptic NR2B NMDAR is proexcitotoxic while synaptic NR2A NMDAR supports neuronal survival [49] . However, experimental data indicate that NR2B NMDAR play a critical role in mediating prosurvival effects of NMDAR stimulation. For instance, ifenprodil reduced survival of dopaminergic neurons in rat midbrain organotypic cultures [32] . It was also shown to induce apoptosis in cultured cortical neurons [47] . In addition, NR2B blockade with either ifenprodil or Ro 25-6981 abolished protection by exogenous NMDA in cortical or hippocampal neurons challenged with a PI3K inhibitor, LY294002 [48] . These results indicate that in several neuronal populations from developing rodent forebrain or midbrain, NR2B can mediate anti-apoptotic NMDAR activity.
CaMKK and CaMKs may be involved in NMDAR-mediated protection.
Role of PI3K/Akt in pro-survival NMDAR signaling
The phosphatidylinositol-3 kinase (PI3K)/Akt pathway is a critical transducer for several major survival signals in CNS neurons [15, 16] . In cerebellar granule, cortical, and hippocampal neurons, PI3K/Akt mediates the pro-survival effects of neurotrophins, insulin or IGF-I [60, [64] [65] [66] . Also, neuroprotective levels of NMDAR activity may stimulate PI3K/Akt pathway to suppress neuronal apoptosis. The importance of PI3K/Akt signaling in the pro-survival activity of NMDARs was demonstrated in cultured rat cerebellear granule neurons [62, [67] [68] [69] . In this model, PI3K inhibition with either LY294002 or wortmanin reduced NMDA protection against apoptosis induced by trophic deprivation in low K + media [62, [67] [68] [69] . Also, NMDA activated PI3K [67] and activated Akt in a PI3K-dependent manner [62, 68] . Finally, expression of a dominant negative mutant form of Akt removed the protection by NMDA [62] . Of note, all the reports indicating PI3K/Akt involvement in NMDA protection used a model of trophic deprivation-induced apoptosis in low K + media. Therefore, PI3K involvement in the NMDA neuroprotection may be specific for this pro-apoptotic stimulus. Indeed, PI3K did not appear to mediate the NMDAR protection in cerebellar granule neurons that were challenged with glutamate excitotoxicity [70] .
The role of PI3K in NMDARdependent survival of other neurons than cerebellar granule cells is unclear. NMDAR activity was reported to increase PI3K/Akt signaling in primary cultures of rodent striatal or cortical neurons [71, 72] . In the rat cortical neuron study, the stimulation was seen only if neuronal activity was inhibited by tetrodotoxin [71] . If no tetrodotoxin was used, NMDAR stimulation inhibited PI3K/Akt signaling. On the other hand, it was reported that increased synaptic activity in cultured rat cortical neurons increased PI3K/Akt activity in an NMDAR-dependent manner [50] . This treatment protected against trophic deprivation by stimulating presumably synaptic NMDAR [50] . As the protection found in this study was removed only by a relatively high concentration of LY294002 (100 µM), it is reasonable to speculate that PI3K activity was not involved in the prosurvival activity of the synaptic NMDAR. This notion is further supported by recent observations that, in cultured rat cortical or hippocampal neurons, various intensities of NMDAR stimulation either reduced or did not affect basal levels of PI3K-dependent phosphorylation of Akt [48, 73] . Moreover, we reported that exogenous NMDA suppressed apoptosis induced by cortical or hippocampal neuron exposure to a PI3K inhibitor, LY294002 [48] . These results indicate that in rat cortical or hippocampal neurons, NMDA protection does not require PI3K activity. Also, it appears that neurons dying as result of reduced PI3K signaling may be protected by the NMDAR-mediated activation of alternative survival pathway/pathways that can replace the missing PI3K activity.
However, in forebrain neurons, PI3K may be involved in NMDAR-mediated protection if a limited NMDAR activation antagonizes certain death stimuli. For instance, Akt activation was found in striatal cell lines isolated from a genetic mouse model of Huntington disease [74] . This activation, that was proposed to be a compensatory survival response, was inhibited by NMDAR antagonists [74] . In addition, Akt was shown to be activated in hippocampal neurons by ischemic preconditioning in rats and gerbils [63, 75] . In rats this was shown to be NMDARdependent [63] . Also, in that model, LY294002 removed the protection, indicating PI3K/Akt involvement [63] .
Although there are multiple identified targets that mediate the antiapoptotic signaling by PI3K/Akt it is not clear which ones are involved in its protective signaling downstream of NMDARs [16] . For instance, it is unresolved if phosphorylations of Bad or FKHRL1, which were shown in cerebellar granule neurons to contribute to pro-survival signaling by PI3K/Akt [76, 77] , occur after protective NMDAR activation. Also, it is unclear if PI3K/Akt-dependent inhibition of GSK3β may contribute to this protection [78] . Interestingly, in the case of ischemic preconditioning, NMDAR-dependent activity of Akt was suggested to inhibit the pro-apoptotic signaling via MKL3/JNK pathway [63] .
While
PI3K/Akt appears to contribute to NMDAR-mediated suppression of trophic deprivation-induced apoptosis in cerebellar granule neurons, its role in anti-apoptotic protection of trophicdeprived forebrain neurons is less evident. However, PI3K/Akt was proposed to participate in NMDAR-mediated signaling that underlies protection by ischemic preconditioning in the rat hippocampus. Clearly, PI3K/Akt involvement in the NMDAR-mediated protection requires further study.
Role of ERK in pro-survival NMDAR signaling
The Extracellular Signal Regulated Kinase 1/2 (ERK1/2) pathway is implicated in mediating protection by neurotrophins (for review see [14, 15] ). In addition, it has been implicated in mediating the survivalenhancing effects of NMDAR stimulation. Gonzalez-Zulueta and colleagues showed that in cultured rat cortical neurons, protective oxygen/glucose deprivation preconditioning activated ERK1/2 via NMDAR [79] . The activation was mediated by increased production of NO resulting in Ras activation [79] . ERK1/2 but not PI3K/Akt blockade completely abolished protective effects of pre-conditioning [79] . Similarly, NMDAR was found to signal through ERK1/2 to protect cultured CGNs against a subsequent glutamate challenge [70] .
Interestingly, DNA damage induced by the neurotoxic anti-cancer drug cisplatin (CPDD) led to NMDAR-dependent activation of ERK1/2 which, in turn, counteracted the apoptotic response to the DNA damage in cultured rat cortical neurons [44] . Further, CPDD enhanced NMDAR signaling to ERK1/2 [44] . The increase of ERK responses involved poly-(ADP-ribose)-polymerase (PARP) [44] . PARP is an enzyme that mobilizes DNA repair but may also lead to energetic deprivation and necrosis [80, 81] . Elevated PARP activity was suggested to increase NMDAR signaling by depeleting neurons of ATP [81] . Importantly, the PARP activation observed in CPDD-treated neurons did not deplete cellular ATP [44] . Therefore, it appears that PARP contributes to the defensive ERK1/2 activation by a mechanism that does not involve disturbed neuronal energetics. Thus, NMDAR may activate protective signaling via ERK1/2 by either stimulating NO production, or by PARP-dependent modulation of NMDAR coupling to ERK1/2. Also, NMDAR stimulation may result in increased release of BDNF that activates ERK1/2 [70] . In addition, there are some reports providing indirect evidence that ERK1/2 may be involved in NMDAR-mediated protection. For instance, ERK1/2 activity was reduced in the brains of rat pups that were treated with NMDAR antagonists [82] . Also, antiexcitotoxic activation of cAMP response element-binding protein (CREB) that was induced in cultured cortical neurons by stimulation of synaptic NMDAR was reduced by ERK inhibition [83] .
To our knowledge there are no direct data that would allow for identification of the downstream mechanisms that mediate protection by NMDAR-activated ERK1/2. A role of gene expression was suggested in NMDA-mediated protection of CGNs [45] . As that protection was also shown to require ERK1/2, the signaling by this pathway may involve transcriptional and/or translational regulation [70] . Consistently with this notion, indirect evidence was presented that one of the important events for the protective ERK1/2 signaling may be activation of a transcription factor, CREB [83] .
ERK1/2 plays a role in NMDARmediated protection against excitotoxicityand DNA damage-induced neuronal death. ERK1/2 appears as a pathway that is involved in the defensive NMDAR signaling activated by stress including genotoxicity or ischemic preconditioning. Its role in NMDAR-mediated protection against developmental apoptosis remains to be tested. Also, the mechanisms that underlie the survival promoting actions of NMDARactivated ERK1/2 require further studies.
Role of GSK3β inhibition in prosurvival NMDAR signaling
Glycogen synthase kinase 3β (GSK3β) is an important regulator of neuronal death (for review see [19, 20] ). Several apoptotic stimuli activate GSK3β while its inhibition protects from cell death [30, 78, [84] [85] [86] [87] [88] . Also, GSK3β may contribute to excitotoxicity by stimulating PP1 and inhibiting CREB [89] . The proapoptotic activity of GSK3β is reduced by several survival signaling pathways including Akt, protein kinase A (PKA), protein kinase C (PKC) or extracellular signal-regulated kinases 1/2 (ERK1/2) (for review see [18] [19] [20] ). These pathways inhibit GSK3β by phosphorylation at the Ser9 residue [90] . In addition, neuronal GSK3β may be regulated in a Ser9-independent manner [91] . Interestingly, inhibition of GSK3β contributes to pro-survival activity of NMDAR.
Using rat pups injected with an NMDAR antagonist, MK801, it was shown that in developing brain, lack of NMDARdependent survival signal triggers activation of GSK3β [92] . This was accompanied by reduced levels of Ser9 phosphorylation and GSK3β translocation to the nucleus [92] . Further, in cultured rat cortical or hippocampal neurons, we observed that antiapoptotic stimulation of NMDAR with exogenous NMDA reduced GSK3β activation that was triggered by the PI3K inhibitor LY294002 [48] . Since these cells were protected from LY294002-induced apoptosis by GSK3β inhibitors [48] , we proposed that NMDA-mediated suppression of GSK3β may underlie the protection. Indeed, NMDA reduced neuronal apoptosis triggered by overexpression of GSK3β [48] . Interestingly, we also found that NMDA did not reverse the reduction in Ser9 phosphorylation that followed PI3K/Akt inhibition [48] . In concert with these observations, NMDA protected against the pro-apoptotic activity of a mutant form of GSK3β with Ser9 residue mutated to Ala [48] . In addition, NMDA did not affect another regulatory phosphorylation of GSK3β at the Tyr216 residue [48] . Therefore, survival stimulation of NMDAR appears to target and inhibit GSK3β using a mechanism that does not involve Ser9 or Tyr216 phosphorylation.
Finally, the role of GSK3β inhibition in NMDAR-mediated survival is supported by observations that GSK3β inhibition with LiCl or with pharmacological inhibitors prevented cultured rat cortical neuron death that was induced by a NR2B-selective NMDAR antagonist, ifenprodil [47] . This indicates that as in the case of low intensity stimulation with exogenous NMDA, also basal NMDAR activity targets the proapoptotic activity of GSK3β. It is important to realize that NMDAR effects on GSK3β depend on the stimulation intensity. For instance, while low intensity stimulation reduced the apoptotic activation of GSK3β [48] , excitotoxic stimulation activated this kinase [89] . Therefore, NMDAR appear to have bidirectional effects on GSK3β.
Inhibition of GSK3β is another signaling event that contributes to NMDARprotection against apoptosis. The identity of a signaling pathway that controls GSK3β in response to protective NMDAR activity requires further studies. In addition, the GSK3β-mediated phosphorylations that are inhibited by the trophic NMDAR activity remain to be determined.
CREB as potential mediator of NMDAdriven survival
Several of the presented signaling kinase pathways affect both transcriptiondependent and transcription-independent events. Indeed, it was suggested that both gene expression-dependent and -independent mechanisms can underlie NMDAR neuroptotection [45, 50] . The notion that NMDAR protects through regulation of gene expression is further supported by the observations that at least two transcription factors, cAMP response element binding protein (CREB) and nuclear factor-κB (NF-κB) may paly a role in prosurvival signaling that is activated by NMDAR.
CREB is a transcription factor that was proposed to control gene expression programs that are required for long-term plasticity [93] , suppression of apoptosis [17] and/or replenishment of the used/damaged components of the neuron including the elements of the synaptic machinery [94] . Interestingly, active cAMP response elements (CREs) were found in a large portion of mammalian genes supporting the replenishment hypothesis [95] . In concert with this, CREB inhibition in adult mice compromises long term neuronal survival and results in neurodegeneration rather that acute apoptosis [96] .
Regulation of CREB is mediated by several posttranslational modifications and protein-protein interactions (For review see [97] ). One of the regulatory mechanisms involves phosphorylation of CREB Ser133 residue that helps to recruit a transcriptional co-activator, CREB binding protein (CBP) to CRE-controlled promoters. The extracellular signals which have been shown to activate CREB include stimulation of TrkB receptors, or NMDAR (For review see [17] ). Interestingly, the kinase pathways that were proposed to activate CREB in response to these signals include such NMDAactivated signal transduction circuitries as ERK1/2, Akt or CaMKIV (For review see [97] ). In consequence, the possible involvement of CREB in pro-survival activity of NMDAR is likely and has been investigated in several studies.
The role of CREB in anti-apoptotic signaling of NMDAR was proposed by Hardingham and colleagues who found that in cultured rat cortical neurons synaptic NMDAR activation robustly induced CREB Ser133 phosphorylation, stimulated CREdependent transcription and suppressed staurosporine induced apoptosis [49] . Also, in rat pups, chronic treatment with NMDAR antagonists induced cerebellar granule neuron apoptosis and reduced the levels of CREB Ser133 phosphorylation [33, 98] . Similar observations were made in cultured cerebellar granule neurons where pSer133 levels were reduced by tophic deprivation in low K + media and this reduction was prevented by NMDA [98] . In addition, neuronal apoptosis induced in forebrains of P7 rat pups by a NMDAR antagonist, MK801, was accompanied by reduced CREB phosphorylation at Ser133 [99] .
The anti-apoptotic role of NMDARdependent CRE transcription was demonstrated in cultured rat cortical neurons [50] . In this model, a 12 hour episode of bicuculline/4-aminopyridine-induced synaptic activity produced NMDARdependent neuroprotection against subsequent trophic deprivation. The protection correlated with an increase in CREB phosphorylation at Ser133 and was removed by overexpressing Inducible cAMP Early Repressor (ICER) which is a naturally occurring inhibitor of CRE-driven transcription [50] .
In addition, CREB was implicated in NMDAR-mediated protection against excitotoxic/ischemic neuronal injury. For instance, in gerbil, CREB activation was triggered by ischemic preconditioning that protected against more severe global ischemia [100] . Both CREB activation and protection were abolished by inhibiting NMDAR with MK801 [100] . In cultured rat hippocampal neurons, both sub-toxic and toxic concentrations of glutamate induced CREB phosphorylation, while a CREBinhibiting CRE decoy oligonucleotide accelerated glutamate-triggered neuronal death [100] . In another study using rat cortical neuron cultures, brief period of synaptic activity induced long-lasting CREB phosphorylation and protection against an excitotoxic insult 24 hours later [83] . Both CREB activation and protection were removed with NMDAR antagonists [83] . In addition, a constitutively active mutant form of CREB reduced excitotoxicity, while a dominant-negative mutant form of CREB blocked protection by synaptic NMDAR activation [83] .
Thus, CREB appears to participate in the NMDAR protection against both trophic deprivation and exitotoxicity. However, it remains to be tested if (i) the protection is because CREB increases expression of some specific survival genes or if (ii) the protection reflects the need for CREB in maintenance of neuronal homeostasis by replenishment of RNAs/proteins that are recycled following NMDAR activation.
Another transcription factor that is implicated in neuronal survival is NF-κB. NF-κB is a member of Rel family of transcription factors (for a review see [21, 101] ). One of the recognized mechanisms of NF-κB regulation involves phosphorylation of the inhibitor of NF-κB (I-κB). That is followed by I-κB degradation and nuclear translocation of NF-κB. Several studies have demonstrated the role of NF-κB in cytoprotection (for a review see [21, 101] ). In addition, it was shown that NF-κB can mediate the anti-apoptotic effects of neurotrophins [102] . Some evidence also points to its possible role in NMDARmediated protection. For instance, in Sexually Dimorphic Nucleus of the PreOptic Area of male rats, blockade of NMDAR induced neuronal apoptosis and reduced DNA binding activity of NF-κB [103] . In addition, NMDAR stimulation increased NF-κB binding activity and promoted I-κB phosphorylation, while protecting against glutamate excitotoxicity in cultured rat cerebellar granule neurons [104] . Moreover, NF-κB-inhibiting decoy oligonucleotide completely abolished NMDA neuroprotection in this model [104] .
Thus, both CREB and NF-κB may be involved in NMDAR mediated survival. A major challenge is to identify the genes that are regulated by these factors to produce protection in NMDAR-stimulated neurons. In addition, it is unclear if other NMDARactivated transcription factors are involved in the protection. Interesting candidates that were shown to be both NMDA-responsive and involved in cell survival in either neuronal or non-neuronal systems include Elk, SRF, NFAT or AP1 [94, [105] [106] [107] [108] [109] [110] . Their contribution to NMDAR protection remains to be elucidated.
Role of trophic factors in NMDARmediated protection
Neurotrophins including brainderived neurotrophic factor (BDNF) have powerful pro-survival effects in different types of neurons challenged with diverse injuries (for a review see [15, 111, 112] ). BDNF supports neuronal survival by acting on TrkB receptors that upon ligand binding become auto-phosphorylated. The protective pathways downstream of TrkB include ERK1/2, PI3K/Akt and CREB. Importantly, like NMDAR, BDNF provides a survival signal for the developing CNS neurons suppressing developmental apoptosis. Interestingly, BDNF expression was shown to be regulated by calcium signaling and CREB (for a review see [113] ). For these reasons, connections between NMDAR protection and BDNF were explored by several studies using either trophic deprivation or excitotoxicity models.
Marini and colleagues reported that antiexcitotoxic protection by NMDRA in cultured rat CGNs was accompanied by increased TrkB phosphorylation suggesting increased BDNF signaling [114] . Also, blocking BDNF signaling by a TrkB kinase inhibitor, K252a or TrkB-IgG fusion protein decreased neuroprotective effects of subtoxic concentrations of NMDA against glutamate exitotoxicity [114] . Interestingly, NMDA stimulation triggered rapid release of BDNF into the culture media. That was followed by a later increase in BDNF mRNA levels [114] . In a subsequent study, it was shown that a likely mechanism of NMDAR-induced increase in BDNF expression involves a transcription factor, NF-κB [104] . In addition, similar role of BDNF in antiexcitotoxic protection by NMDAR was reported in rat hippocampal neuron cultures or rat explant retinal cultures [31, 46, 115] . Finally, in rat CGNs, NMDAR-activated BDNF protection against excitotoxicity was suggested to involve ERK1/2 [70] . Therefore, BDNF appears to play an important role in NMDAR-mediated protection against excitotoxic cell death.
Also, NMDAR protection against apoptosis induced by trophic deprivation or that found during developmental was suggested to involve BDNF. For instance, in trophic-deprived cultured rat cerebellar granule neurons kept in low K + media, NMDAR stimulation blocked apoptosis while increasing BDNF expression [68] . Furthermore, interference with TrkB signaling blocked the NMDAR-induced protection. Interestingly, in this model, NMDAR was suggested to protect via PI3K/Akt pathway that was activated by NMDAR-stimulated BDNF [68] . In cultured rat cerebellar granule neurons, similar BDNF-mediated pathway was proposed to underlie the protection by a brief exposure to NMDA that followed trophic deprivation in low K + media [69] . In addition, in rat pups, forebrain neuron apoptosis induced by MK801 was accompanied by reduced BDNF mRNA levels [82] . Similar decreases were also reported in cultured cortical neurons that were treated with MK801 [82] . In this system, BDNF addition prevented MK801-induced apoptosis [82] suggesting that NMDAR-driven expression of BDNF may play an important role in supporting neuronal survival during development.
Although most published studies evaluated role of BDNF as an effector of the pro-survival NMDAR signaling, other growth/trophic factors may be also involved in this process. For instance, expressions of GDNF or erythropoietin or erythropoietin receptor were reduced in the brains of MK801-treated rat pups [82, 99] . Furthermore, recombinant erythropoietin partially blocked neuronal loss and restored BDNF gene expression in MK801-treated pups [99] . Thus, trophic factors including BDNF and erythropoietin are regulated by NMDAR activity and seem to contribute to NMDAR-mediated protection. While there are more data on possible mechanisms of The NMDAR regulation of other components of the apoptotic machinery including caspases is less well established. Its possible existence is indicated by the observations that in cultured hippocampal neurons, subtoxic concentrations of glutamate and neuroprotective concentrations of NMDA significantly elevated expression of a caspase inhibitor, X-chromosome linked member of Inhibitor of Apoptosis Proteins (XIAP) [120] . The significance of XIAP upregulation for NMDAR-mediated protection remains to be tested NMDAR-mediated modulation of BDNF expression, the mechanisms underlying rapid increase in BDNF release from NMDAR-stimulated neurons remain to be identified.
Regulation of the apoptotic machinery in NMDAR protection
Earlier studies demonstrated that survival signals in neurons frequently target several basic components of apoptotic machinery (for a review see [14] [15] [16] ). These include modulation of the expression levels of antiapoptotic or proapoptotic members of Bcl-2 family as well as postranslational modifications of these proteins [116] . In addition, pro-apoptotic proteases, caspases may be targeted by survival signaling pathways that modulate the expression of caspase inhibitors or directly interfere with caspase activation by posttranslational modifications [117] [118] [119] . NMDAR-mediated protection may involve at least some regulatory mechanisms that directly affect the apoptotic machinery. For instance, NMDA blockade in neonatal rat brain, downregulated expression of an antiapoptotic protein Bcl-2 which is a founding member of the Bcl-2 family [82, 103] . On the other hand, in cultured rat cerebellar granule neurons, NMDAR stimulation increased expression of Bcl-2 and its antiapoptotic relative, Bcl-Xl while decreased the levels of a pro-apoptotic member of Bcl-2 family, Bax. [70] . In addition, NMDAR was suggested to trigger CREB-mediated increase in Bcl-2 expression that was associated with improved survival of glutamate exposed hippocampal neurons [100] . Finally, in neuroblastoma cells, NMDAR protection against trophic deprivation was proposed to be by Aktmediated phosphorylation and inactivation of a pro-apoptotic member of Bcl-2 family, Bad [51] . Thus, NMDAR-activated survival signaling seems to affect the activity of Bcl-2 family members.
Conclusions and perspectives
Despite NMDAR involvement in excitotoxicity, their physiological activity supports neuronal survival during development. Also, moderate NMDAR activation including that follows mild injuries may provide protection against severe injuries by toxic chemicals, ischemia or excitotoxicity. These imply that the neuroprotective potential of the currently available NMDAR antagonists may be limited due to inhibition of the pro-survival signaling by NMDAR. Therefore there is a need for novel NMDAR antagonists that will be selective for the excitotoxic activity of the NMDAR while unaffecting or increasing the effects of NMDAR stimulation. In order to initiate design of such drugs one has to identify the signaling switches that determine the different outcomes of NMDAR activation including the critical mediators of NMDAR-stimulated survival.
It appears that NMDAR-mediated protection may involve diverse transduction mechanisms that regulate different survival effectors (Figure 1, Tables 1 and 2 ). It appears that these mediators include signaling kinases which regulate survival by affecting the activity of transcription factors or by using gene-expression-independent mechanisms. Regulation of trophic factor expression and/or release, as well as regulation of the components of apoptotic machinery have been implicated as effector mechanisms in NMDAR-stimulated survival networks. Which mechanisms mediate the NMDAR protection is likely determined by the cell type, developmental stage and also by the character of the insult that NMDAR protect against.
The emerging field of NMDARmediated survival signaling faces several important challanges. For instance, while NMDAR-mediated regulation of gene expression has attracted more attention, little is known about transcription-independent mechanisms employed by NMDAR to protect. Also, the design and scope of the published NMDAR protection studies was usually biased by the previous findings from the neurotrophin field. Therefore, the major mediators of the NMDAR protection may still remain unidentified while such players as ERK1/2, PI3K/Akt, GSK3β, CREB, BDNF or Bcl-2 may be involved in some secondary regulatory events. In addition, the published studies did not test how inhibition of various signaling mediators that were proposed to act downstream of the NMDAR, affected the function of the NMDAR. As NMDAR may be regulated by CREB-driven transcription, membrane targeting/endocytosis and/or by phosphorylation [121] [122] [123] , the inhibition of protective NMDAR signaling by an inhibitor of a kinase or a transcription factor may reflect loss of functional NMDAR rather than participation in a NMDARinduced signaling network. Nevertheless, the apparent importance of NMDAR signaling for neuronal survival both during development and in the adult CNS warrants further studies to identify the pathways that are involved in the protection. It also indicates a novel opportunity for neuroprotective manipulations that could harness the pro-survival activity of NMDAR. On the other hand, emerging evidence for the existence of protective NMDAR signaling in transformed cells may provide new treatments for cancer. 
